Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreaves Lansdown Regulatory News (HL.)

Share Price Information for Hargreaves Lansdown (HL.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 812.00
Bid: 814.20
Ask: 817.80
Change: 3.60 (0.45%)
Spread: 3.60 (0.442%)
Open: 812.00
High: 836.60
Low: 811.80
Prev. Close: 808.40
HL. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

2 Feb 2018 07:00

RNS Number : 7125D
Hargreaves Lansdown PLC
02 February 2018
 

Hargreaves Lansdown plc

 

("Hargreaves Lansdown plc", "the Company" or "HL") 

 

2nd February 2018

 

Appointment of New Chair and Board changes

 

The Board of Hargreaves Lansdown plc ("the Board") is pleased to announce the appointment of Deanna W. Oppenheimer as a Director with immediate effect and as Non-executive Chair and Chair of the Nomination Committee with effect from 7 February 2018.

Deanna currently has roles as the Senior Independent Director and Chair of Remuneration Committee of Tesco plc, non-executive director and Chair of the Remuneration Committee of Whitbread plc, and as a non-executive director of AXA Group and Worldpay (previously Worldpay plc).

Her rich executive experience includes transforming the retail banking division at Barclays and Deanna is also founder of CameoWorks, a consumer focused boutique advisory firm which works with fintech businesses and other technology disrupters.

In the last 5 years, she has also held a directorship at NCR Corp.

 

Mike Evans will stand down as Non-Executive Chairman and retire from the Board with effect from 7 February 2018, and Chris Barling will stand down as a Non-Executive Director and the Senior Independent Non-Executive Director ("SID") from the same date. Shirley Garrood is appointed as SID with effect from 7 February 2018, succeeding Chris Barling.

 

Comment

Chris Hill, CEO of Hargreaves Lansdown, said "We are delighted to announce Deanna's appointment. The knowledge and experience that she has built up throughout her executive and non-executive career, with its focus around customer engagement and technology, make her an ideal Chair to lead the Board into our next phase of growth.

Mike joined the Board of Hargreaves Lansdown in September 2006 prior to the IPO in May 2007 and his integrity and leadership style has contributed strongly to the development of the Board and our governance framework. We have benefitted from his extensive experience and challenge as the Group has grown into the market leading, client-focused, FTSE100 business it is today. On behalf of the Board and indeed from everyone at HL, I would like to express my gratitude to Mike for his immense contribution to the Group.

Chris has served on the Board since August 2010 and as the SID and Chair of the Remuneration Committee since October 2013. His technological insight and entrepreneurial thinking have been of great value. We are also grateful for his role in the search which has resulted in Deanna's appointment and we thank him and wish him well with his business ventures."

Deanna Oppenheimer, Chair-elect of Hargreaves Lansdown, said "Hargreaves Lansdown is an innovative market leader for very good reasons and I was immediately attracted by the people, their values and the client first culture. Against a backdrop of a huge savings gap, political uncertainty and technological change, our challenge is to continue to make people's financial lives as easy as we can and help them to save and invest with confidence. I am excited by the opportunities ahead of us and am looking forward to playing my part in the HL story."

Deanna will cease two of her roles by mid-2018 and these will be announced by the respective Boards at the appropriate time.

 

As at 2 February 2018, Deanna has confirmed that she owns no shares in Hargreaves Lansdown PLC.

Other than the directorships disclosed above, there are no matters required by paragraphs LR 9.6.13R (1) to (6) of the listing rules to be disclosed.

For further information please contact:

Hargreaves Lansdown +44 (0) 117 988 9967

Chris Hill, Chief Executive

James Found, Investor Relations

Danny Cox, Media Relations

 

LEI number: 2138008ZCE93ZDSESG90

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMGGZGMRGRZZ
Date   Source Headline
1st May 20249:27 amRNSDirector Declaration
30th Apr 20247:00 amRNSTrading Statement
25th Apr 20242:43 pmRNSDirector Declaration
19th Apr 20241:56 pmRNSDirector/PDMR Shareholding
4th Apr 202411:24 amRNSDirector/PDMR Shareholding
7th Mar 20241:54 pmRNSDirector/PDMR Shareholding
28th Feb 20244:01 pmRNSDirector/PDMR Shareholding
27th Feb 20242:29 pmRNSDirector/PDMR Shareholding
26th Feb 20244:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20244:05 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSHalf-year Report
9th Feb 202412:10 pmRNSNotice of Results
6th Feb 202412:08 pmRNSDirectorate Change
1st Feb 20247:09 amRNSDirector Declaration
17th Jan 202412:03 pmRNSDirector Declaration
2nd Jan 202410:06 amRNSDirector Declaration
20th Dec 202312:50 pmRNSDirector/PDMR Shareholding
14th Dec 202312:06 pmRNSDirector Declaration
11th Dec 20237:17 amRNSDirector Declaration
8th Dec 20234:33 pmRNSResult of AGM
6th Dec 20238:10 amRNSDirector Declaration
29th Nov 20237:00 amRNSDirectorate Change
7th Nov 20231:54 pmRNSNotice of AGM
23rd Oct 20238:00 amRNSAnnual Financial Report
19th Oct 20237:00 amRNSTrading Statement
12th Oct 20234:10 pmRNSDirector/PDMR Shareholding
12th Oct 20234:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:21 pmRNSDirector/PDMR Shareholding
21st Sep 20234:15 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
1st Sep 20239:59 amRNSNotice of Results
19th Jul 20237:00 amRNSTrading Statement
17th Jul 20234:32 pmRNSDirectorate Change
10th Jul 202311:00 amRNSDirectorate Change
15th Jun 202312:13 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirectorate Change
15th May 20234:51 pmRNSDirector/PDMR Shareholding
10th May 20234:01 pmRNSDirector/PDMR Shareholding
4th May 202311:00 amRNSDirector Declaration
4th May 20237:00 amRNSTrading Statement
25th Apr 20232:13 pmRNSDirector/PDMR Shareholding
1st Mar 202310:22 amRNSDirector/PDMR Shareholding
15th Feb 20237:00 amRNSHalf-year Report
27th Jan 202312:02 pmRNSDirector Declaration
23rd Jan 202310:10 amRNSNotice of Results
19th Jan 20233:33 pmRNSHolding(s) in Company
20th Dec 20222:01 pmRNSDirector/PDMR Shareholding
16th Dec 202211:05 amRNSDirector Declaration
8th Dec 20228:00 amRNSDirectorate Change
24th Oct 20223:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.